Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol. 2020 05 01; 6(5):676-684.

View in: PubMed

subject areas

Antibodies, Monoclonal, Humanized
Breast Neoplasms
Female
Humans
Neoadjuvant Therapy
Neoplasm Staging
Programmed Cell Death 1 Receptor

authors with profiles

Nora T. Jaskowiak
Rita Nanda
Ronald N. Cohen
Jeffrey B. Matthews